165 related articles for article (PubMed ID: 20607308)
21. Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study.
Matsuhashi N; Kudo M; Yoshida N; Murakami K; Kato M; Sanuki T; Oshio A; Joh T; Higuchi K; Haruma K; Nakada K
J Gastroenterol; 2015 Dec; 50(12):1173-83. PubMed ID: 25851931
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
Takeuchi T; Oota K; Harada S; Edogawa S; Kojima Y; Sanomura M; Sakaguchi M; Hayashi K; Hongoh Y; Itabashi T; Kitae H; Hoshimoto M; Takeuchi N; Higuchi K
Intern Med; 2015; 54(2):97-105. PubMed ID: 25742999
[TBL] [Abstract][Full Text] [Related]
23. It is possible to classify non-erosive reflux disease (NERD) patients into endoscopically normal groups and minimal change groups by subjective symptoms and responsiveness to rabeprazole -- a report from a study with Japanese patients.
Kusano M; Shirai N; Yamaguchi K; Hongo M; Chiba T; Kinoshita Y;
Dig Dis Sci; 2008 Dec; 53(12):3082-94. PubMed ID: 18465242
[TBL] [Abstract][Full Text] [Related]
24. Practice pattern of gastroenterologists for the management of GERD under the minimal influence of the insurance reimbursement guideline: a multicenter prospective observational study.
Lee KJ; Kim JI; Park JS; Moon BS; Kim SG; Chun JH; Jung HY; Choi CH; Chun SW; Song GA; Choi MG; Chun HJ
J Korean Med Sci; 2011 Dec; 26(12):1613-8. PubMed ID: 22147999
[TBL] [Abstract][Full Text] [Related]
25. Gastroesophageal reflux disease after diagnostic endoscopy in the clinical setting.
Zschau NB; Andrews JM; Holloway RH; Schoeman MN; Lange K; Tam WC; Holtmann GJ
World J Gastroenterol; 2013 Apr; 19(16):2514-20. PubMed ID: 23674853
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese.
Mishima I; Adachi K; Arima N; Amano K; Takashima T; Moritani M; Furuta K; Kinoshita Y
Scand J Gastroenterol; 2005 Sep; 40(9):1005-9. PubMed ID: 16211699
[TBL] [Abstract][Full Text] [Related]
27. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults.
Molina-Infante J; Ferrando-Lamana L; Ripoll C; Hernandez-Alonso M; Mateos JM; Fernandez-Bermejo M; Dueñas C; Fernandez-Gonzalez N; Quintana EM; Gonzalez-Nuñez MA
Clin Gastroenterol Hepatol; 2011 Feb; 9(2):110-7. PubMed ID: 20920599
[TBL] [Abstract][Full Text] [Related]
28. Endoscopic grading of gastroesophageal flap valve helps predict proton pump inhibitor response in patients with gastroesophageal reflux disease.
Cheong JH; Kim GH; Lee BE; Choi MK; Moon JY; Ryu DY; Kim DU; Song GA
Scand J Gastroenterol; 2011 Jul; 46(7-8):789-96. PubMed ID: 21615222
[TBL] [Abstract][Full Text] [Related]
29. Little necessity of acid inhibition against proton pump inhibitor rebound effects and prior helicobacter pylori eradication therapy in gastric ulcer patients: a randomized prospective study.
Wada Y; Ito M; Takata S; Kitamura S; Takamura A; Tatsugami M; Imagawa S; Matsumoto Y; Tanaka S; Yoshihara M; Chayama K
Hepatogastroenterology; 2009; 56(91-92):624-8. PubMed ID: 19621668
[TBL] [Abstract][Full Text] [Related]
30. Clinical symptoms of FSSG in gastroesophageal reflux disease are critical for PPI treatment: Japanese multi-centers with 185 patients.
Komatsu-Tanaka M; Iwakiri R; Fujimoto K; Fujiwara Y; Inamori M; Tanaka J; Shimatani T; Akiyama J; Ando T; Manabe N; Kinjo F; Deguchi R; Kusano M
Dig Endosc; 2012 Nov; 24(6):407-11. PubMed ID: 23078431
[TBL] [Abstract][Full Text] [Related]
31. Does BMI affect the clinical efficacy of proton pump inhibitor therapy in GERD? The case for rabeprazole.
Pace F; Coudsy B; DeLemos B; Sun Y; Xiang J; LoCoco J; Casalini S; Li H; Pelosini I; Scarpignato C
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):845-51. PubMed ID: 21900784
[TBL] [Abstract][Full Text] [Related]
32. Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan.
Fujiwara Y; Higuchi K; Shiba M; Yamamori K; Watanabe Y; Sasaki E; Tominaga K; Watanabe T; Oshitani N; Arakawa T
Am J Gastroenterol; 2005 Apr; 100(4):754-8. PubMed ID: 15784015
[TBL] [Abstract][Full Text] [Related]
33. Sleep dysfunction in Japanese patients with gastroesophageal reflux disease: prevalence, risk factors, and efficacy of rabeprazole.
Fujiwara Y; Kohata Y; Kaji M; Nebiki H; Yamasaki T; Sasaki E; Hayakawa T; Machida H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
Digestion; 2010; 81(3):135-41. PubMed ID: 20090330
[TBL] [Abstract][Full Text] [Related]
34. Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study.
Suzuki T; Matsushima M; Masui A; Tsuda S; Imai J; Nakamura J; Tsukune Y; Uchida T; Yuhara H; Igarashi M; Koike J; Mine T
World J Gastroenterol; 2015 Apr; 21(16):5023-31. PubMed ID: 25945018
[TBL] [Abstract][Full Text] [Related]
35. Results of short-and long-term medical treatment of gastroesophageal reflux disease (GERD).
Pohle T; Domschke W
Langenbecks Arch Surg; 2000 Aug; 385(5):317-23. PubMed ID: 11026702
[TBL] [Abstract][Full Text] [Related]
36. Obesity does not affect treatment outcomes with proton pump inhibitors.
Sharma P; Vakil N; Monyak JT; Silberg DG
J Clin Gastroenterol; 2013 Sep; 47(8):672-7. PubMed ID: 23442835
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes of patients with symptomatic gastroesophageal reflux disease treated with vonoprazan.
Shinozaki S; Osawa H; Kobayashi Y; Sakamoto H; Hayashi Y; Miura Y; Kawarai Lefor A; Yamamoto H
Scand J Gastroenterol; 2018 Aug; 53(8):897-904. PubMed ID: 30056768
[TBL] [Abstract][Full Text] [Related]
38. Does Helicobacter pylori infection influence response rate or speed of symptom control in patients with gastroesophageal reflux disease treated with rabeprazole?
de Boer W; de Wit N; Geldof H; Hazelhoff B; Bergmans P; Smout A; Tytgat G
Scand J Gastroenterol; 2006 Oct; 41(10):1147-54. PubMed ID: 16990199
[TBL] [Abstract][Full Text] [Related]
39. Erosive Esophagitis Portends a Benign Clinical Course in the Majority of Patients.
Bi D; Katzka DA; Lavey CJ; Geno DM; Ravi K
Dig Dis Sci; 2020 Nov; 65(11):3244-3252. PubMed ID: 31907769
[TBL] [Abstract][Full Text] [Related]
40. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
